T11	Effect 144 202	reducing the duration of neutropenia and risk of infection
T13	Subject 52 89	an RA patient treated with gold salts
T14	Treatment 97 142	granulocyte colony-stimulating factor (G-CSF)
T16	Drug 97 134	granulocyte colony-stimulating factor
T12	Potential_therapeutic_event 21 29	overcome
E1	Potential_therapeutic_event:T12 arg:T13 arg2:T14 arg3:T11
T1	Treat-Disorder 30 48	severe neutropenia
T2	Sub-Disorder 55 57	RA
T3	Effect 30 48	severe neutropenia
T4	Adverse_event 49 51	in
E2	Adverse_event:T4 arg:T3 arg2:T6
T5	Treat-Disorder 55 57	RA
T6	Treatment 79 89	gold salts
T7	Drug 79 89	gold salts
R1	has Arg1:T6 Arg2:T5	
R2	has Arg1:T14 Arg2:T1	
R3	has Arg1:T13 Arg2:T2	
